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Abstract Factor Vila (fVIIa) consists of a heavy chain (serine 
protease domain) and a light chain (Y-carboxyglutamic acid 
(Gla)-rich and epidermal growth factor (EGF)-like domains). 
The light chain, primarily the first EGF-like domain, appears to 
provide most of the binding energy in the interaction with tissue 
factor (TF). The Ca2+-binding sites in the protease domain and in 
the first EGF-like domain influence activity and interaction with 
TF, but the contribution from the Ca2+-binding sites in the Gla 
domain has not been established. We have compared the soluble 
TF (sTF)-binding properties of intact fVIIa to those of a 
fragment comprising almost the entire light chain and a small 
disulphide-linked peptide from the protease domain. Half-
maximal binding of fVIIa and the light chain to sTF occurred 
around 0.3 and 1 mM Ca2+, respectively. The Ca2+ dependence 
of light-chain binding indicates an influence of Ca2+ binding to 
the Gla domain on the interaction between fVIIa and sTF. 
Comparison of the sTF-binding properties of fVIIa and a 
truncated variant lacking the Gla domain suggests that this 
domain interferes with sTF association at suboptimal Ca2+ 
concentrations. The light chain of fVIIa associated 5-fold slower 
with sTF than did fVIIa at saturating Ca2+ concentrations, 
whereas the dissociation of its complex with sTF was at least 
100-fold faster than that of fVIIa:sTF. This gave a dissociation 
constant of 1-2 uM for the interaction between the light chain 
and sTF compared to about 3 nM for the fVIIa:sTF interaction. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Exposure of the integral transmembrane protein tissue fac-
tor (TF) to blood results in initiation of the coagulation cas-
cade through the formation of a factor Vila (fYIIa):TF com-
plex [1-4]. The binding to TF potentiates the fVIIa-catalyzed 
activation of the macromolecular substrates factors IX [5] and 
X [6] as well as the fVIIa amidolytic activity [7,8]. The degree 
of amidolytic activity enhancement depends on pH with a 
minimum around the physiological value and, interestingly, 
the pH optimum of fVIIa differs from that of the fVIIa:sol-
uble TF (sTF) complex [9]. 
Biochemical studies and the structure of the lYIIa:sTF 
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Abbreviations: fVIIa, factor Vila; des(l-38)-fVIIa, fVIIa lacking the 
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plus 248-266 of fVIIa; Gla, y-carboxyglutamic acid; EGF, epidermal 
growth factor; TF, tissue factor; sTF, the soluble, extracellular part of 
TF (residues 1-219); K,i, equilibrium dissociation constant 
complex have shown that the interaction between fVIIa and 
TF involves several areas on both molecules [10,11]. The ma-
jor contact surfaces on fVIIa are located in the first epidermal 
growth factor (EGF)-like domain and in the protease domain. 
Results from a mutagenesis study [12] and the hydrophobic 
nature of the interface [11] suggest that the interaction be-
tween the first EGF-like domain of fVIIa and TF tethers 
the enzyme to the cofactor. In a physiological setting, fVIIa 
presumably interacts both with TF and, via the y-carboxyglu-
tamic acid (Gla) domain, with the phospholipid surface sur-
rounding TF. Both interactions are important for high affinity 
between fVIIa and membrane-embedded TF. It is not known 
whether lYIIa in solution binds TF directly or first binds to 
the phospholipid, but the initial contact most likely involves 
the Gla and first EGF-like domains close to the membrane 
surface. 
The presence of Ca2+ ions facilitates fVIIa binding to sTF 
as measured by functional titration [13-16] or by biophysical 
techniques [17,18]. The Ca2+-loaded form of fVIIa has a dra-
matically higher affinity for sTF (dissociation constant 
Kd)=l-5 nM) than has the apo form (Kd > 1 uM) [15,19]. 
The Ca2+ dependence of fVIIa:sTF complex formation, as-
sessed by sTF-induced enhancement of fVIIa amidolytic ac-
tivity, is characterized by a half-maximum around 0.2-0.3 mM 
[14,19-21]. TF does not bind Ca2+ [22], whereas fVIIa binds a 
total of nine Ca2+ ions, seven of which are found in the N-
terminal Gla domain [11,19]. The remaining two Ca2+ ions 
are found in sites of relatively higher affinity in the first EGF-
like domain [19,23] and in the protease domain [13,19], re-
spectively, with Kd values around 0.1 mM. A (Vila molecule 
mutated at a putative Ca2+-coordinating residue (Glu220) in 
the protease domain appears to bind slightly weaker to sTF 
and requires a significantly higher Ca2+ concentration for 
maximal activity than does wild-type fVIIa [13]. Abolishment 
of the Ca2+ site in the first EGF-like domain results in a 
decreased affinity for sTF [24]. It has been suggested that 
low-affinity Ca2+ sites are important for high-affinity interac-
tion between fVIIa and TF [22], but no clear evidence of an 
involvement of Gla-dependent Ca2+-binding sites has been 
presented. In addition, intact and N-terminally truncated 
(Gla-domainless) fVIIa bind sTF with similar Ca2+ depend-
ences [21]. Once the fYIIa:sTF complex is formed, Ca2+ ap-
pears not to be essential for its activity [15,25]. 
In this paper, surface plasmon resonance is used to charac-
terize the sTF-binding properties of the light chain of fVIIa 
(fVII-GlaEGFxc), a region containing eight out of the nine 
Ca2+-binding sites present in intact fVIIa. The results show 
that considerable binding energy is involved in the light 
chain :sTF interaction and demonstrate a role for Gla-depend-
ent Ca2+-binding sites in optimal sTF binding. A comparison 
of the sTF-binding kinetics of fVIIa and Gla-domainless 
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fVIIa (des(l-38)-fVIIa) reveals an obstructive effect of the Gla 
domain on the association of fVIIa with sTF at suboptimal 
Ca2+ concentrations, at which the protese and first EGF-like 
domains, but not the Gla domain, are virtually saturated with 
Ca2+. 
2. Materials and methods 
2.1. Proteins 
Recombinant fVIIa was produced in baby hamster kidney cells and 
purified as described [26]. Des(l-38)-fVIIa was obtained by fVIIa 
autodigestion under Ca2+-free conditions [27] and fVII-GlaEGFNc 
was isolated after limited tryptic cleavage of fVIIa [21]. sTF was ex-
pressed in E. coli, refolded and purified according to published pro-
cedures [28,29]. 
2.2. Tissue factor-binding experiments 
The binding of fVIIa, des(l-38)-fVIIa and fVII-GlaEGFNc to sTF 
was measured in a BIAcore instrument (Biacore AB, Uppsala, Swe-
den) essentially as described [30,31]. The analytes, the concentrations 
of which are given in the figure legends together with the amounts of 
sTF coupled to the sensor chip, were in 20 mM HEPES, pH 7.4, 
containing 0.1 M NaCl, 0.02% Tween 80 and various concentrations 
of CaCb or 2 mM EDTA. All injections in a series of experiments 
were made over the same sTF-coated surface which retained its bind-
ing capacity over the experimental time frame. In the experiments 
designed to determine the on- and off-rates (Figs. 2 and 3), the asso-
ciation and dissociation phases lasted for 7 and 6 min, respectively. In 
the Ca2+-dependence experiments (Fig. 1), association was allowed to 
proceed for 12 min. The data was evaluated employing a one-site 
model and the BIAevaluation 2.1 software. 
3. Results 
The binding of fVIIa, des(l-38)-fVIIa, and fYII-GlaEGFNC 
to sTF was measured at different Ca2+ concentrations. The 
analyte concentrations in this set of experiments were chosen 
to rapidly reach equilibrium levels of binding to the sTF sites 
on the sensor chip under optimal conditions. Half-maximal 
binding of fVIIa was achieved around 0.3 mM Ca2+ and of 
des(l-38)-fVIIa between 0.1 and 0.2 mM (Fig. 1). This is in 
agreement with the Ca2+ dependence of the sTF-dependent 
amidolytic activity of fVIIa:sTF and des(l-38)-fVIIa:sTF 
[14,19-21]. Both proteins bound maximally at Ca2+ concen-
trations above 1 mM. The fVII-GlaEGFNc fragment required 
higher Ca2+ levels in order to bind sTF. No significant bind-
ing was observed at 0.2 mM and half-maximum occurred 
around 1 mM, roughly corresponding to the average affinity 
of the Ca2+-binding sites in the Gla domain [19,21]. This 
suggests that saturation of Gla-dependent Ca2+-binding sites 
is necessary for optimal sTF binding. The thorough character-
ization [21] and unique Ca2+ dependence of fvTI-GlaEGFNc 
excludes the possibility that contaminating fVIIa contributed 
to the observed sTF binding. 
Because it could be inferred from the Ca2+ dependence of 
fVII-GlaEGFNc binding to sTF that an optimal interaction 
requires saturation of Ca2+-binding sites in the Gla domain, it 
was investigated whether this is true also for the interaction of 
fVIIa with sTF. The kinetics at optimal (5 mM) and subopti-
mal (0.5 mM) Ca2+ concentrations were analyzed in the pres-
ence (fVIIa) and absence (des(l-38)-fVIIa) of the Gla domain. 
A profound effect was observed on the interaction of fVIIa 
with sTF upon lowering of the Ca2+ concentration (Fig. 2A). 
This could be attributed to a 6-fold decrease in the rate of 
association, being 3.2 XlO5 M _ 1 s _ 1 at 5 mM Ca2+ and 
5.3 XlO4 M _ 1 s _ 1 at 0.5 mM Ca2+ (and even lower at 0.2 
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Fig. 1. Ca2+ dependence of the interactions between sTF and fVIIa, 
des(l-38)-fYIIa and fVII-GlaEGFNc- Overlays of sensorgrams of 
the interactions of fVIIa (100 nM, A), des(l-38)-fVIIa (300 nM, B), 
and fVII-GlaEGFNC (5 uM, C) with sTF at the indicated Ca
2+ con-
centrations (mM) are shown. The curves indicated by '0' were ac-
quired in the presence of 2 mM EDTA. 910 (A and C) or 330 (B) 
resonance units of sTF were immobilized on the sensor chip. The 
sensorgrams were corrected by subtracting the signal obtained when 
injecting the samples over a blank surface. 
mM Ca2 +; see Fig. 1A). The dissociation rate remained the 
same (1.3XlO - 3 s_ 1 and 1.2X10-3 s_1, respectively). This 
yields an increase in K& from 4 nM at 5 mM Ca2+ to 23 nM 
at 0.5 mM Ca2+. Dramatic effects on fVII-GlaEGFNc binding 
to sTF was also evident upon lowering of the Ca2+ concen-
tration (Fig. 1C). In contrast, when the experiment was per-
formed with des(l-38)-fVIIa, only marginal changes in the 
association (10% slower) and dissociation (30% faster) rates 
were observed upon lowering the Ca2+ concentration (Fig. 
2B). It can also be deduced from Fig. 1 that, although the 
steady-state level of both fVIIa and des(l-38)-fVIIa binding 
to sTF dropped with decreasing Ca2+ concentrations, the time 
to reach steady-state level increased significantly for fVIIa but 
was much less affected for des(l-38)-fVIIa. To exclude the 
possibility that increased electrostatic repulsion between the 
non-saturated Gla domain and the dextran matrix in which 
sTF is immobilized causes the decreased association rate, 
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Fig. 2. The interactions of fVIIa and des(l-38)-fVIIa with sTF at 
optimal and suboptimal Ca2+ concentrations. The corrected sensor-
grams show the binding of fVIIa (60 nM, A) and des(l-38)-fVIIa 
(120 nM, B) to sTF at 5 mM (top curves) and 0.5 mM Ca2+ (bot-
tom curves). 330 resonance units of sTF had been coupled to the 
sensor chip. 
fVIIa binding to a Ca2+-independent monoclonal antibody 
was measured at 0.5 and 5 mM Ca2+. There was no visible 
difference in binding kinetics showing that fVIIa has the same 
access to sTF at both Ca2+ concentrations (not shown). These 
results demonstrate that the decreased rate of association of 
fVIIa with sTF at suboptimal Ca2+ concentrations is indeed 
an effect of the Gla domain being (only) partially saturated 
and, as a consequence thereof, structurally disordered. 
Des(1^14)-fVIIa has been found to have slightly higher affin-
ity than fVIIa for sTF in the absence of Ca2+ [15]. Our results 
suggest that fVIIa in fact has a lower (or similar) affinity for 
sTF compared to that of des(l-38)-fVIIa at Ca2+ concentra-
tions below 0.5 mM due to what appears to be steric hin-
drance by the non-saturated Gla domain. 
The binding of GlaEGF fragments of fVIIa to TF has been 
demonstrated by their ability to competitively inhibit 
fVIIa:TF activity [32,33], but the kinetics have not been in-
vestigated. The kinetics of the fVII-GlaEGFNC:sTF interac-
tion (Fig. 3) were found to be strikingly different from those 
of the interaction between intact fVIIa and sTF. The esti-
mated rate of fVII-GlaEGFNc association with sTF, 4 x l 0
4 
M _ 1 s _ 1 , is about 5-fold slower than that of fVIIa association 
with sTF [18,30,31,34]. The most dramatic difference was seen 
in the rate of dissociation, which was approximately 100-fold 
faster for the fVII-GlaEGFNc:sTF complex, or 0.05-0.1 s"
1, 
than for fVIIa:sTF. The resulting K$ for the interaction be-
tween fVII-GlaEGFNc and sTF is between 1 and 2 uM. 
4. Discussion 
Under physiological circumstances, fVIIa interacts both 
with TF and the phospholipid surface in which TF is an-
chored. Both interactions are Ca2+-dependent (occur opti-
mally at plasma concentration) and important for high-affin-
ity binding of fVIIa to membrane-associated TF. The 
interactions are sensitive to changes in the Ca2+ concentration 
in approximately the same interval and studies of the Ca2+ 
dependence of either event using lipidated TF is complicated 
by a simultaneous effect on the other. However, sTF has been 
used to characterize the protein-protein interaction between 
fVIIa and TF and we have used it for instance to study the 
role of the membrane-binding Gla domain of fVIIa in the 
interaction with TF. The biosensor technique employed in 
this study has proven suitable for the study of the fVIIa:sTF 
interaction and generates binding data in agreement with 
those obtained in solution phase assays [15,30]. It allows 
real-time monitoring of binding to sTF, not only of the enzy-
matically active fVIIa and des(l-38)-fVIIa but also of frag-
ments such as rVII-GlaEGFNC. It has been inferred from X-
ray structural [11] and alanine scanning mutagenesis [12] data 
that contacts mediated by the light chain, or rather the first 
EGF-like domain, glues fVIIa to sTF. We have directly shown 
that the interaction between rVII-GlaEGFNC and sTF, based 
on the estimated binding constants, retains 2/3 of the binding 
energy of the fVIIa:sTF interaction. The affinity of fVII-
GlaEGFNC for sTF was 500-1000-fold lower than that of 
fVIIa mainly due to an increased rate of dissociation from 
sTF. The slower formation and very rapid dissociation of 
the f"VII-GlaEGFNC:sTF complex compared to fVIIarsTF 
could be anticipated based on the reduced number of poten-
tial docking sites present on fVII-GlaEGFNC and the reduced 
number of stabilizing interactions between the fragment and 
sTF. Effects, albeit less pronounced, on both association and 
dissociation rates have been observed with a fVIIa mutant 
where Gin replaced the TF-interactive residue Arg79 in the 
first EGF-like domain [18]. Thus, fVII-GlaEGFNc, which 
lacks a major contact area (the protease domain), and the 
fVIIa R79Q mutant, which is defective in a major contact 
area, both exhibit decreased association and increased disso-
ciation rates. Increased dissociation rates have also been ob-
served for Gla-domainless forms of fVIIa [30] but the effects 
of the N-terminal truncations (residues 1-38 or 1^44) were 
smaller than that of deleting the protease domain (as in 
fVII-GlaEGFNc), conceivably explained by the relative con-
tributions of these regions of fVIIa to the interaction with sTF 
200 400 600 
Time (s) 
800 1000 
Fig. 3. Corrected sensorgrams for the interaction between fVII-
GlaEGFNC and sTF. The concentration of fVII-GlaEGFNC during 
the association phase was 4 uM (top curve) or 1 uM (bottom 
curve). The Ca2+ concentration was 5 mM and 640 resonance units 
of sTF were coupled to the sensor chip. 
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Fig. 4. Schematic model of the TF-interactive regions of fVIIa at different degrees of Ca2+ saturation. Left: In the absence of Ca2+, the areas 
on fVIIa interacting in a Ca2+-dependent manner with sTF are not complementary to the cof actor and the low-affinity interaction is mediated 
by Ca2+-independent contacts. The contact between the second EGF-like domain and sTF is assumed to be Ca2+-independent. The Gla domain 
is internally flexible. Middle: At the suboptimal Ca2+ concentration used in this study, the Ca2+-binding sites in the protease and first EGF-
like domains are nearly (>75%) saturated, whereas the Gla domain requires more Ca2+ to be fully ordered. Right: At 5 mM Ca2+, the Gla 
domain is properly ordered and oriented resulting in an optimal fit between fVIIa and sTF. 
[11]. Regions within the first EGF-like and protease domains 
of fVIIa are likely to function as sTF docking sites [11] and 
have to be available for rapid association to occur. This im-
plies that fVIIa and des(l-38)-fVIIa should associate equally 
fast with sTF, which they do at optimal Ca2+ concentrations 
[30], and that fVII-GlaEGFNc should associate slower with 
sTF since the protease domain is missing, which is also true. 
Lowering of the Ca2+ concentration to 0.5 mM results in a 
fVIIa conformation which associates slower to sTF, kineti-
cally resembling fVIIa mutated at the C-terminal Gla residue 
[31]. On the other hand, des(l-38)-fVIIa associates at an al-
most optimal rate at 0.5 mM Ca2+, illustrating a functional 
difference between fVIIa and Gla-domainless fVIIa in their 
modes of interacting with sTF not demonstrable in earlier 
studies. The observation that the rate of dissociation of the 
fVIIa:sTF complex is unaffected by lowering of the Ca2+ 
concentration is in agreement with previous studies showing 
that after complex formation Ca2+ is not necessary for its 
integrity and activity [15,25]. Furthermore, it suggests that 
sTF establishes and stabilizes the correct contacts with the 
flexible Gla domain of fVIIa in the complex at 0.5 mM 
Ca2+ although the spacing of the relevant Phe residues [11] 
in free fVIIa is not optimal. The structures of the apo and 
Ca2+-loaded forms of the Gla domain of factor IX infer that 
the sTF-interactive Phe residues in the Gla domain of fVIIa 
are solvent-exposed at both 0.5 and 5 mM Ca2+ [35,36]. 
The fVIIa:TF interaction and amidolytic activity are Ca2+-
dependent [13-15,19-21]. Site-directed mutagenesis has re-
vealed the importance of the Ca2+-binding sites in the first 
EGF-like and protease domains for the expression of fVIIa 
activity and sTF-binding epitopes [13,24]. Although the true 
value of the Ca2+ concentration at which fVIIa attains half-
maximal sTF-binding capability is debatable, it appears to be 
higher than the K^s reported for the two Ca2+-binding sites 
mentioned above [19,23]. A conceivable explanation is that 
Ca2+-binding sites in the Gla domain play a role in the 
Ca2+-dependent fVIIa activity in the presence of sTF, i.e. in 
sTF binding, considering the broad range of affinities repre-
sented within this group of sites [37]. These sites have been 
hypothesized to be important for the expression of TF-inter-
active epitopes [38]. However, the Ca2+ concentrations re-
quired for half-maximal sTF binding of intact and Gla-do-
mainless fVIIa were almost identical [21]. The results obtained 
with fVIIa and des(l-38)-fVIIa using the biosensor are in 
agreement with these observations but also clearly demon-
strate different sTF-binding kinetics, especially at suboptimal 
Ca2+ concentrations. They provide the first direct demonstra-
tion of the need for a Ca2+-loaded Gla domain for optimal 
sTF binding. I hypothesize that the unsaturated Gla domain 
interferes with the interaction between the neighbouring EGF-
like domain and sTF, although more long-range effects are 
possible, and thereby precludes rapid association. We have 
shown by CD that Ca2+ binding to the Gla domain brings 
about ordering of structural elements [29], and it is conceiv-
able that the flexible apo form causes sterical problems in the 
interaction with sTF. In addition, our results with fVII-
GlaEGFNc unambiguously show that Gla-dependent Ca2+ 
sites of relatively low affinity are pivotal for sTF binding. It 
is important to remember that the Gla and first EGF-like 
domains bind Ca2+ with the same affinity in the fragment as 
they do in intact fVIIa [21], shown also to be the case for 
corresponding fragments from protein C [39], factor IX [40] 
and factor X [41]. Hence, the removal of the protease domain 
per se is not the reason for the Ca2+ dependence of fVII-
GlaEGFNctsTF complex formation, but the binding experi-
ments with the fragment provide valuable insights into the 
role of the Ca2+-binding sites in the Gla domain in the inter-
action between fVIIa and sTF. 
The Ca2+ dependence of the fVIIa:sTF interaction appears 
to be a complex function of the affinities of several Ca2+-
binding sites. The importance of the Ca2+-binding site in 
the protease domain for activity has been demonstrated [13], 
although none of the residues in the Ca2+-binding loop inter-
act directly with sTF [11]. Perhaps this site is most important 
for fVIIa activity and less for sTF binding. The Ca2+ con-
former of the first EGF-like domain is required for optimal 
recognition of sTF/TF [24], although the only residue that 
contacts sTF and is likely to be affected by Ca2+ binding to 
this domain is Gin64 [11,42]. The present study demonstrates 
that a certain extent of saturation of the Gla domain appears 
to be essential to avoid steric hindrance. On this basis, a 
schematic model of the Ca2+-induced changes in fVIIa that 
facilitate its interaction with sTF can be put forward (Fig. 4). 
It should be kept in mind that fVIIa binds sTF in the absence 
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of Ca2+ and the binding energy is about 2/3 of that at optimal 
Ca2+ concentrations [15,19]. 
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